Case Report
Copyright ©The Author(s) 2024.
World J Clin Cases. Feb 16, 2024; 12(5): 995-1003
Published online Feb 16, 2024. doi: 10.12998/wjcc.v12.i5.995
Table 2 Histological features and outcomes of pancreatic solitary fibrous tumors
No
Ref.
Immunohistochemistry
Outcome
Follow-up
1Lüttges et al[1]CD34, CD99, Bcl-2, vimentinAlive20 months
2Chatti et al[8]CD34, CD99, Bcl-2, vimentinDeath3 d
3Gardini et al[9]CD34, CD99, Bcl-2, vimentin, SMAAlive16 months
4Miyamoto et al[10]CD34, Bcl-2Alive7 months
5Kwon et al[11]CD34, CD99, vimentinNANA
6Srinivasan et al[12]CD34, Bcl-2Alive7 months
7Chetty et al[13]CD34, CD99, Bcl-242 mo6 v
8Ishiwatari et al[14]CD34, Bcl-2Alive42 months
9Sugawara et al[15]CD34NANA
10Santos et al[16]CD34, betacateninNANA
11Tasdemir et al[17]CD34, Bcl-2, beta-catenin, vimentin, Ki67 < 2%Alive3 months
12van der et al[18]CD34, CD99, Bcl-2NANA
13Chen et al[19]CD34, Bcl-2, vimentin, CD68, muscle-specific actinAlive30 months
14Hwang et al[20]CD34, Bcl-2, muscle-specific actin, CD10, ER, PRAlive30 months
15Baxter et al[21]CD34, Bcl-2NANA
16Estrella et al[22]CD34, Bcl-2, keratin (rare), p16, p53Alive40 months
17Han et al[23]CD34, CD99No progression10 months
18Murakami et al[24]STAT6, CD34, Bcl-2, ACTH, POMC, NSEDeath4 months
19Spasevska et al[3]CD34, vimentin, CD99, Bcl-2, nuclear betacateninDeath1 wk
20Paramythiotis et al[7]CD34, CD99, Bcl-2 vimentin, S-100Alive40 months
21D'Amico FE et al[25]STAT6, CD34Alive24 months
22Oana et al[26]CD34, Bcl-2Alive36 months
23Sheng et al[27]CD34, vimentin, SMA, Ki67 < 3%Alive12 months
24Geng et al[28]STAT6, CD34, Bcl-2, CD31, PHH-3, D2-40, Ki67 > 10%Alive6 months
25Qian et al[29]STAT6, CD34, Bcl-2, Ki67 10%Alive10 months
26Rogers et al[30]STAT6, CD34, Bcl-2, CD99Alive4 months
27Taguchi et al[31]STAT6, CD34, Bcl-2, vimentin, cytokeratin AE1/AE3Alive12 months
28Jariwalla et al[32]STAT6, CD34NANA
29Marotti et al[33]STAT6, CD34Alive6 months
30Addeo et al[6]STAT6, CD34, Bcl-2, Ki67 7%NANA
31Rodriguez et al[2]STAT6Alive12 months
32Jones et al[34]STAT6, CD34Alive1 months
33Liu et al[35]CD34, STAT6, CD99Alive6 months
34Present case
TAT6, CD34, Bc1-2, Vimentin, CD99, Ki67 40%Alive3 months